Glucotrack (GCTK) Shares Outstanding (2010 - 2025)
Glucotrack's (GCTK) quarterly Shares Outstanding (Entity) came in at $621094.0 in Q4 2025, up 11184.41% YoY from N/an in Q4 2024, and down 30.94% on a QoQ basis from $899410.0 in Q3 2025.
Glucotrack (GCTK) Shares Outstanding (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 16 years of Shares Outstanding (Entity) data on file, last reported at $621094.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 11184.41% year-over-year to $621094.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $621094.0 (up 11184.41% YoY) and the FY2025 annual result came in at $621094.0, up 11184.41% from the prior year.
- Shares Outstanding (Entity) slipped to $621094.0 in Q4 2025, from $899410.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $2.6 million in Q1 2022 to a low of $2575.0 in Q1 2021.
- A 5-year average of $626561.3 and a median of $4688.5 in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 100064.02% — and 2022, when it slumped 99.9%.
- Tracing GCTK's Shares Outstanding (Entity) over 5 years: stood at $2.6 million in 2021, then plunged by 99.9% to $2584.0 in 2022, then jumped by 34.79% to $3483.0 in 2023, then soared by 58.02% to $5504.0 in 2024, then soared by 11184.41% to $621094.0 in 2025.
- The last three Shares Outstanding (Entity) figures came in at $621094.0 (Q4 2025), $899410.0 (Q3 2025), and $494504.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 621,094.00 |
| Sep 30, 2025 | 899,410.00 |
| Jun 30, 2025 | 494,504.00 |
| Mar 31, 2025 | 169,379.00 |
| Dec 31, 2024 | 5,504.00 |
| Sep 30, 2024 | 4,663.00 |
| Jun 30, 2024 | 4,564.00 |
| Mar 31, 2024 | 4,161.00 |
| Dec 31, 2023 | 3,461.00 |
| Sep 30, 2023 | 3,829.00 |
| Jun 30, 2023 | 3,594.00 |
| Mar 31, 2023 | 2,584.00 |
| Dec 31, 2022 | 2,580.00 |
| Sep 30, 2022 | 2,579.00 |
| Jun 30, 2022 | 2,579.00 |
| Mar 31, 2022 | 2.58 Mn |
| Dec 31, 2021 | 2.58 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.58 Mn |
| Mar 31, 2021 | 2,575.00 |